世界のACTH欠乏症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global ACTH Deficiency Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3753
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ACTH欠乏症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（先天性、後天性）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ACTH欠乏症治療の市場動向
・企業の競争状況、市場シェア
・ACTH欠乏症治療の種類別市場規模と予測2016-2027（先天性、後天性）
・ACTH欠乏症治療の用途別市場規模と予測2016-2027（病院、薬局、その他）
・ACTH欠乏症治療の北米市場規模2016-2027（アメリカ、カナダ）
・ACTH欠乏症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ACTH欠乏症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ACTH欠乏症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ACTH欠乏症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Breckenridge Pharmaceutical、Hikma Pharmaceuticals、Pfizer、Mylan Pharmaceuticals、Sandoz、LabCorp、Epitope Diagnostics）
・結論

ACTH is an adrenocorticotropic hormone, which is a hormone secreted by the anterior pituitary gland, which can maintain the normal form and function of the adrenal glands. The main role of ACTH is to promote the secretion of glucocorticoids by the adrenal cortex, maintaining the normal physiological functions and metabolism of the human body. ACTH Deficiency Treatment refers to the cure for the patient that is lack of ACTH.

Market Analysis and Insights: Global ACTH Deficiency Treatment Market
The global ACTH Deficiency Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global ACTH Deficiency Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global ACTH Deficiency Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global ACTH Deficiency Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global ACTH Deficiency Treatment market.

Global ACTH Deficiency Treatment Scope and Market Size
ACTH Deficiency Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global ACTH Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Congenital
Acquired
In terms of type, the global ACTH Deficiency Treatment market can be classified into congenital and acquired.

Segment by Application
Hospitals
Drug Stores
Others
In terms of distribution channel, the global ACTH Deficiency Treatment market can be divided into hospitals, drug stores, and others.

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Breckenridge Pharmaceutical
Hikma Pharmaceuticals
Pfizer
Mylan Pharmaceuticals
Sandoz
LabCorp
Epitope Diagnostics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ACTH Deficiency Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Congenital
1.2.3 Acquired
1.3 Market by Application
1.3.1 Global ACTH Deficiency Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Drug Stores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global ACTH Deficiency Treatment Market Perspective (2016-2027)
2.2 ACTH Deficiency Treatment Growth Trends by Regions
2.2.1 ACTH Deficiency Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 ACTH Deficiency Treatment Historic Market Share by Regions (2016-2021)
2.2.3 ACTH Deficiency Treatment Forecasted Market Size by Regions (2022-2027)
2.3 ACTH Deficiency Treatment Industry Dynamic
2.3.1 ACTH Deficiency Treatment Market Trends
2.3.2 ACTH Deficiency Treatment Market Drivers
2.3.3 ACTH Deficiency Treatment Market Challenges
2.3.4 ACTH Deficiency Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top ACTH Deficiency Treatment Players by Revenue
3.1.1 Global Top ACTH Deficiency Treatment Players by Revenue (2016-2021)
3.1.2 Global ACTH Deficiency Treatment Revenue Market Share by Players (2016-2021)
3.2 Global ACTH Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by ACTH Deficiency Treatment Revenue
3.4 Global ACTH Deficiency Treatment Market Concentration Ratio
3.4.1 Global ACTH Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ACTH Deficiency Treatment Revenue in 2020
3.5 ACTH Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players ACTH Deficiency Treatment Product Solution and Service
3.7 Date of Enter into ACTH Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 ACTH Deficiency Treatment Breakdown Data by Type
4.1 Global ACTH Deficiency Treatment Historic Market Size by Type (2016-2021)
4.2 Global ACTH Deficiency Treatment Forecasted Market Size by Type (2022-2027)

5 ACTH Deficiency Treatment Breakdown Data by Application
5.1 Global ACTH Deficiency Treatment Historic Market Size by Application (2016-2021)
5.2 Global ACTH Deficiency Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America ACTH Deficiency Treatment Market Size (2016-2027)
6.2 North America ACTH Deficiency Treatment Market Size by Type
6.2.1 North America ACTH Deficiency Treatment Market Size by Type (2016-2021)
6.2.2 North America ACTH Deficiency Treatment Market Size by Type (2022-2027)
6.2.3 North America ACTH Deficiency Treatment Market Size by Type (2016-2027)
6.3 North America ACTH Deficiency Treatment Market Size by Application
6.3.1 North America ACTH Deficiency Treatment Market Size by Application (2016-2021)
6.3.2 North America ACTH Deficiency Treatment Market Size by Application (2022-2027)
6.3.3 North America ACTH Deficiency Treatment Market Size by Application (2016-2027)
6.4 North America ACTH Deficiency Treatment Market Size by Country
6.4.1 North America ACTH Deficiency Treatment Market Size by Country (2016-2021)
6.4.2 North America ACTH Deficiency Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe ACTH Deficiency Treatment Market Size (2016-2027)
7.2 Europe ACTH Deficiency Treatment Market Size by Type
7.2.1 Europe ACTH Deficiency Treatment Market Size by Type (2016-2021)
7.2.2 Europe ACTH Deficiency Treatment Market Size by Type (2022-2027)
7.2.3 Europe ACTH Deficiency Treatment Market Size by Type (2016-2027)
7.3 Europe ACTH Deficiency Treatment Market Size by Application
7.3.1 Europe ACTH Deficiency Treatment Market Size by Application (2016-2021)
7.3.2 Europe ACTH Deficiency Treatment Market Size by Application (2022-2027)
7.3.3 Europe ACTH Deficiency Treatment Market Size by Application (2016-2027)
7.4 Europe ACTH Deficiency Treatment Market Size by Country
7.4.1 Europe ACTH Deficiency Treatment Market Size by Country (2016-2021)
7.4.2 Europe ACTH Deficiency Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific ACTH Deficiency Treatment Market Size (2016-2027)
8.2 Asia-Pacific ACTH Deficiency Treatment Market Size by Type
8.2.1 Asia-Pacific ACTH Deficiency Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific ACTH Deficiency Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific ACTH Deficiency Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific ACTH Deficiency Treatment Market Size by Application
8.3.1 Asia-Pacific ACTH Deficiency Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific ACTH Deficiency Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific ACTH Deficiency Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific ACTH Deficiency Treatment Market Size by Region
8.4.1 Asia-Pacific ACTH Deficiency Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific ACTH Deficiency Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America ACTH Deficiency Treatment Market Size (2016-2027)
9.2 Latin America ACTH Deficiency Treatment Market Size by Type
9.2.1 Latin America ACTH Deficiency Treatment Market Size by Type (2016-2021)
9.2.2 Latin America ACTH Deficiency Treatment Market Size by Type (2022-2027)
9.2.3 Latin America ACTH Deficiency Treatment Market Size by Type (2016-2027)
9.3 Latin America ACTH Deficiency Treatment Market Size by Application
9.3.1 Latin America ACTH Deficiency Treatment Market Size by Application (2016-2021)
9.3.2 Latin America ACTH Deficiency Treatment Market Size by Application (2022-2027)
9.3.3 Latin America ACTH Deficiency Treatment Market Size by Application (2016-2027)
9.4 Latin America ACTH Deficiency Treatment Market Size by Country
9.4.1 Latin America ACTH Deficiency Treatment Market Size by Country (2016-2021)
9.4.2 Latin America ACTH Deficiency Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa ACTH Deficiency Treatment Market Size (2016-2027)
10.2 Middle East & Africa ACTH Deficiency Treatment Market Size by Type
10.2.1 Middle East & Africa ACTH Deficiency Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa ACTH Deficiency Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa ACTH Deficiency Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa ACTH Deficiency Treatment Market Size by Application
10.3.1 Middle East & Africa ACTH Deficiency Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa ACTH Deficiency Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa ACTH Deficiency Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa ACTH Deficiency Treatment Market Size by Country
10.4.1 Middle East & Africa ACTH Deficiency Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa ACTH Deficiency Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Breckenridge Pharmaceutical
11.1.1 Breckenridge Pharmaceutical Company Details
11.1.2 Breckenridge Pharmaceutical Business Overview
11.1.3 Breckenridge Pharmaceutical ACTH Deficiency Treatment Introduction
11.1.4 Breckenridge Pharmaceutical Revenue in ACTH Deficiency Treatment Business (2016-2021)
11.1.5 Breckenridge Pharmaceutical Recent Development
11.2 Hikma Pharmaceuticals
11.2.1 Hikma Pharmaceuticals Company Details
11.2.2 Hikma Pharmaceuticals Business Overview
11.2.3 Hikma Pharmaceuticals ACTH Deficiency Treatment Introduction
11.2.4 Hikma Pharmaceuticals Revenue in ACTH Deficiency Treatment Business (2016-2021)
11.2.5 Hikma Pharmaceuticals Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer ACTH Deficiency Treatment Introduction
11.3.4 Pfizer Revenue in ACTH Deficiency Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Company Details
11.4.2 Mylan Pharmaceuticals Business Overview
11.4.3 Mylan Pharmaceuticals ACTH Deficiency Treatment Introduction
11.4.4 Mylan Pharmaceuticals Revenue in ACTH Deficiency Treatment Business (2016-2021)
11.4.5 Mylan Pharmaceuticals Recent Development
11.5 Sandoz
11.5.1 Sandoz Company Details
11.5.2 Sandoz Business Overview
11.5.3 Sandoz ACTH Deficiency Treatment Introduction
11.5.4 Sandoz Revenue in ACTH Deficiency Treatment Business (2016-2021)
11.5.5 Sandoz Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp ACTH Deficiency Treatment Introduction
11.6.4 LabCorp Revenue in ACTH Deficiency Treatment Business (2016-2021)
11.6.5 LabCorp Recent Development
11.7 Epitope Diagnostics
11.7.1 Epitope Diagnostics Company Details
11.7.2 Epitope Diagnostics Business Overview
11.7.3 Epitope Diagnostics ACTH Deficiency Treatment Introduction
11.7.4 Epitope Diagnostics Revenue in ACTH Deficiency Treatment Business (2016-2021)
11.7.5 Epitope Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global ACTH Deficiency Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Congenital
Table 3. Key Players of Acquired
Table 4. Global ACTH Deficiency Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global ACTH Deficiency Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global ACTH Deficiency Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global ACTH Deficiency Treatment Market Share by Regions (2016-2021)
Table 8. Global ACTH Deficiency Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global ACTH Deficiency Treatment Market Share by Regions (2022-2027)
Table 10. ACTH Deficiency Treatment Market Trends
Table 11. ACTH Deficiency Treatment Market Drivers
Table 12. ACTH Deficiency Treatment Market Challenges
Table 13. ACTH Deficiency Treatment Market Restraints
Table 14. Global ACTH Deficiency Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global ACTH Deficiency Treatment Market Share by Players (2016-2021)
Table 16. Global Top ACTH Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ACTH Deficiency Treatment as of 2020)
Table 17. Ranking of Global Top ACTH Deficiency Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by ACTH Deficiency Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players ACTH Deficiency Treatment Product Solution and Service
Table 21. Date of Enter into ACTH Deficiency Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global ACTH Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global ACTH Deficiency Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global ACTH Deficiency Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global ACTH Deficiency Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global ACTH Deficiency Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global ACTH Deficiency Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global ACTH Deficiency Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global ACTH Deficiency Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America ACTH Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America ACTH Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America ACTH Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America ACTH Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America ACTH Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America ACTH Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe ACTH Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe ACTH Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe ACTH Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe ACTH Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe ACTH Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe ACTH Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific ACTH Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific ACTH Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific ACTH Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific ACTH Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific ACTH Deficiency Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific ACTH Deficiency Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America ACTH Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America ACTH Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America ACTH Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America ACTH Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America ACTH Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America ACTH Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa ACTH Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa ACTH Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa ACTH Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa ACTH Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa ACTH Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa ACTH Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Breckenridge Pharmaceutical Company Details
Table 62. Breckenridge Pharmaceutical Business Overview
Table 63. Breckenridge Pharmaceutical ACTH Deficiency Treatment Product
Table 64. Breckenridge Pharmaceutical Revenue in ACTH Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 65. Breckenridge Pharmaceutical Recent Development
Table 66. Hikma Pharmaceuticals Company Details
Table 67. Hikma Pharmaceuticals Business Overview
Table 68. Hikma Pharmaceuticals ACTH Deficiency Treatment Product
Table 69. Hikma Pharmaceuticals Revenue in ACTH Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 70. Hikma Pharmaceuticals Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer ACTH Deficiency Treatment Product
Table 74. Pfizer Revenue in ACTH Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Mylan Pharmaceuticals Company Details
Table 77. Mylan Pharmaceuticals Business Overview
Table 78. Mylan Pharmaceuticals ACTH Deficiency Treatment Product
Table 79. Mylan Pharmaceuticals Revenue in ACTH Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 80. Mylan Pharmaceuticals Recent Development
Table 81. Sandoz Company Details
Table 82. Sandoz Business Overview
Table 83. Sandoz ACTH Deficiency Treatment Product
Table 84. Sandoz Revenue in ACTH Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 85. Sandoz Recent Development
Table 86. LabCorp Company Details
Table 87. LabCorp Business Overview
Table 88. LabCorp ACTH Deficiency Treatment Product
Table 89. LabCorp Revenue in ACTH Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 90. LabCorp Recent Development
Table 91. Epitope Diagnostics Company Details
Table 92. Epitope Diagnostics Business Overview
Table 93. Epitope Diagnostics ACTH Deficiency Treatment Product
Table 94. Epitope Diagnostics Revenue in ACTH Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 95. Epitope Diagnostics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ACTH Deficiency Treatment Market Share by Type: 2020 VS 2027
Figure 2. Congenital Features
Figure 3. Acquired Features
Figure 4. Global ACTH Deficiency Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Drug Stores Case Studies
Figure 7. Others Case Studies
Figure 8. ACTH Deficiency Treatment Report Years Considered
Figure 9. Global ACTH Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global ACTH Deficiency Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global ACTH Deficiency Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global ACTH Deficiency Treatment Market Share by Regions (2022-2027)
Figure 13. Global ACTH Deficiency Treatment Market Share by Players in 2020
Figure 14. Global Top ACTH Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ACTH Deficiency Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by ACTH Deficiency Treatment Revenue in 2020
Figure 16. Global ACTH Deficiency Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global ACTH Deficiency Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America ACTH Deficiency Treatment Market Share by Type (2016-2027)
Figure 20. North America ACTH Deficiency Treatment Market Share by Application (2016-2027)
Figure 21. North America ACTH Deficiency Treatment Market Share by Country (2016-2027)
Figure 22. United States ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe ACTH Deficiency Treatment Market Share by Type (2016-2027)
Figure 26. Europe ACTH Deficiency Treatment Market Share by Application (2016-2027)
Figure 27. Europe ACTH Deficiency Treatment Market Share by Country (2016-2027)
Figure 28. Germany ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific ACTH Deficiency Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific ACTH Deficiency Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific ACTH Deficiency Treatment Market Share by Region (2016-2027)
Figure 38. China ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America ACTH Deficiency Treatment Market Share by Type (2016-2027)
Figure 46. Latin America ACTH Deficiency Treatment Market Share by Application (2016-2027)
Figure 47. Latin America ACTH Deficiency Treatment Market Share by Country (2016-2027)
Figure 48. Mexico ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa ACTH Deficiency Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa ACTH Deficiency Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa ACTH Deficiency Treatment Market Share by Country (2016-2027)
Figure 54. Turkey ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE ACTH Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Breckenridge Pharmaceutical Revenue Growth Rate in ACTH Deficiency Treatment Business (2016-2021)
Figure 58. Hikma Pharmaceuticals Revenue Growth Rate in ACTH Deficiency Treatment Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in ACTH Deficiency Treatment Business (2016-2021)
Figure 60. Mylan Pharmaceuticals Revenue Growth Rate in ACTH Deficiency Treatment Business (2016-2021)
Figure 61. Sandoz Revenue Growth Rate in ACTH Deficiency Treatment Business (2016-2021)
Figure 62. LabCorp Revenue Growth Rate in ACTH Deficiency Treatment Business (2016-2021)
Figure 63. Epitope Diagnostics Revenue Growth Rate in ACTH Deficiency Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界のアルギナーゼ欠損症治療市場規模・現状・予測（2021年-2027年）

Global Arginase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3851 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、アルギナーゼ欠損症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の亜鉛欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Zinc Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5049 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、亜鉛欠乏症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口剤、注射剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のACTH＆GH機能検査市場規模・現状・予測（2021年-2027年）

Global ACTH and GH Function Tests Market Size, Status and Forecast 2021-2027
QFJ1-3752 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ACTH＆GH機能検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血、尿、その他）、用途別市場規模（病院、診断研究所、外来手術センター、その他ホームケア）、主要地域別市場規模（北米、アメリカ、欧州...

世界のオルニチントランスカルバミラーゼ（OTC）欠損症治療市場規模・現状・予測（2021年-2027年）

Global Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4628 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、オルニチントランスカルバミラーゼ（OTC）欠損症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、...

世界のオルニチントランスカルバミラーゼ欠損症治療市場規模・現状・予測（2021年-2027年）

Global Ornithine Transcarbamylase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5918 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、オルニチントランスカルバミラーゼ欠損症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧...

世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年）

Global CDKL5 Deficiency Disorder (CDD) Market Size, Status and Forecast 2021-2027
QFJ1-3983 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、CDKL5欠乏症（CDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来型医薬品、新型医薬品）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界のアルギナーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年）

Global Arginase Deficiency Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3850 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、アルギナーゼ欠損症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のα1アンチトリプシン欠乏症増強療法市場規模・現状・予測（2021年-2027年）

Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3783 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、α1アンチトリプシン欠乏症増強療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（グラシア、アララストNP、プロラスチンC、その他）、用途別市場規模（病院、専門診療所）、主要地域別市場規模（北米、アメ...

世界のオルニチン-トランスカルバミラーゼ欠損症市場規模・現状・予測（2021年-2027年）

Global Ornithine-Transcarbamylase Deficiency Market Size, Status and Forecast 2021-2027
QFJ1-4629 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、オルニチン-トランスカルバミラーゼ欠損症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DTX-301、SEL-313、SHP-641、PRX-OTC、その他）、用途別市場規模（病院、クリニック、その...

世界のビオチニダーゼ欠損症市場規模・現状・予測（2021年-2027年）

Global Biotinidase Deficiency Market Size, Status and Forecast 2021-2027
QFJ1-5622 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ビオチニダーゼ欠損症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（重度ビオチニダーゼ欠損症、部分的ビオチニダーゼ欠損症）、用途別市場規模（病院、専門クリニック、ドラッグストア、小売薬局、オンライン薬...

世界のACTH＆GH機能検査市場規模・現状・予測（2021年-2027年） Adenocorticotropic hormone (ACTH) is a hormone produced and secreted by the anterior pituitary gland. It is also called corticotropin or serum ACTH. The function of the ACTH is to regulate the level of steroid hormone cortisol, which is regulated by the adrenal gland. Growth hormone (GH) is a peptid…
世界のアルギナーゼ欠損症治療市場規模・現状・予測（2021年-2027年） Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood. Market Analysis and Insights: Global Arginase Deficiency Treatment Market The global Arginase Deficiency Treatme…
世界の亜鉛欠乏症治療市場規模・現状・予測（2021年-2027年） Fill zinc, it is the microelement zinc that compensatory human body needs, filling zinc is in human body growth development, immunity, vitamin to wait to having extremely important effect. Market Analysis and Insights: Global Zinc Deficiency Treatment Market The global Zinc Deficiency Treatment mark…
世界のオルニチントランスカルバミラーゼ（OTC）欠損症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ornithine Transcarbamylase (OTC) Deficiency Treatment Market The global Ornithine Transcarbamylase (OTC) Deficiency Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-s…
世界のオルニチントランスカルバミラーゼ欠損症治療市場規模・現状・予測（2021年-2027年） Ornithine transcarbamylase (OTC) deficiency is a genetic disorder arising due to inadequate levels of OTC, an enzyme that helps decompose and eliminate unwanted nitrogen from the human body. This process is also known as the urea cycle. Deficiency of this enzyme causes excessive nitrogen accumulatio…